Stents, a commonly performed surgical procedure used to remediate damage from coronary artery disease, are another often ill-advised “remedy” for heart disease. Three studies18,19,20 published in 2017 and 2018 reveal just how ineffective this procedure is. There are a number of parameters that are crucial for evaluating the efficacy of a treatment for heart disease, including:
- Mortality — Will the patient actually live longer as a result of that intervention?
- The risk of heart attack as a result of the intervention
- Alleviation of angina (chest pain)
Earlier research had already dismissed the use of percutaneous interventions (PCI) for most of these parameters, showing the use of stents had no impact on long-term rates of death, nonfatal myocardial infarctions (MI) or hospitalization rates for acute coronary syndrome.
The sole indication left for the use of stents was angina, as some of the findings showed it helped reduce prevalence of chest pain. Alas, these studies show even this parameter is unaffected by stent placement.
In one of these studies,21 200 participants with severe single vessel blockage were selected. During the initial six weeks, all patients underwent an exercise test followed by intensive medical treatment, after which they were randomly assigned to two groups.
The first underwent a PCI during which coronary angioplasty was performed and a stent was placed. The second group also underwent a PCI procedure with an angiogram but without a balloon angioplasty or stent placement. At the conclusion of the six weeks, patients again underwent an exercise test and were questioned about their symptoms.
Lo and behold, there was no difference in chest pain (angina) between the treatment group and the sham group. Both groups experienced nearly identical improvements in exercise tolerance and no difference in reported improvements of their symptoms.
Article From: https://articles.mercola.com